- Home
- Automated
- List of product information
- PACOFEN TABLETS [SIN06271P]
PACOFEN TABLETS [SIN06271P]
Active ingredients: PACOFEN TABLETS
Last updated 26 October 2025
Product Info
PACOFEN TABLETS
[SIN06271P]
Product information
Active Ingredient and Strength | CAFFEINE ANHYDROUS - 30 MG |
Dosage Form | TABLET |
Manufacturer and Country | BEACONS PHARMACEUTICALS PTE. LTD. - SINGAPORE |
Registration Number | SIN06271P |
Licence Holder | TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD. |
Forensic Classification | PHARMACY ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | N02BE51 |
INDICATIONS:
For relief of aches and pain e.g., headache, toothache and dysmenorrhoea. Codeine is not recommended for the treatment of post-operative pain following surgical procedures such as tonsillectomy or adenoidectomy in children and adolescents below 18 years old due to the increased risk of respiratory depression.
DOSAGE:
Adults: 1–2 tablets
These doses may be given 3–4 times daily as required (Max. 6 tablets a day).
Children and adolescents
Codeine should not be used in children below 12 years old. In those 12 years old and above, codeine may be used for the short-term treatment of acute moderate pain which is not relieved by analgesics such as Ibuprofen or paracetamol alone. The lowest effective dose should be used for the shortest possible duration.
CONTRA-INDICATIONS:
Contraindicated in patients with bronchial asthma, increased intracranial pressure, respiratory depression and nephropathy.